Mass Spectrometry Imaging of Cassette-Dosed Drugs for Higher Throughput Pharmacokinetic and Biodistribution Analysis
- 8 August 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 86 (16) , 8473-8480
Abstract
Cassette dosing of compounds for preclinical drug plasma pharmacokinetic analysis has been shown to be a powerful strategy within the pharmaceutical industry for increasing throughput while decreasing the number of animals used. Presented here for the first time is data on the application of a cassette dosing strategy for label-free tissue distribution studies. The aim of the study was to image the spatial distribution of eight nonproprietary drugs (haloperidol, bufuralol, midazolam, clozapine, terfenadine, erlotinib, olanzapine, and moxifloxacin) in multiple tissues after oral and intravenous cassette dosing (four compounds per dose route). An array of mass spectrometry imaging technologies, including matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI), liquid extraction surface analysis tandem mass spectrometry (LESA-MS/MS), and desorption electrospray ionization mass spectrometry (DESI-MS) was used. Tissue analysis following intravenous and oral administration of discretely and cassette-dosed compounds demonstrated similar relative abundances across a range of tissues indicating that a cassette dosing approach was applicable. MALDI MSI was unsuccessful in detecting all of the target compounds; therefore, DESI MSI, a complementary mass spectrometry imaging technique, was used to detect additional target compounds. In addition, by adapting technology used for tissue profiling (LESA-MS/MS) low spatial resolution mass spectrometry imaging (∼1 mm) was possible for all targets across all tissues. This study exemplifies the power of multiplatform MSI analysis within a pharmaceutical research and development (R&D) environment. Furthermore, we have illustrated that the cassette dosing approach can be readily applied to provide combined, label-free pharmacokinetic and drug distribution data at an early stage of the drug discovery/development process while minimizing animal usage.Keywords
This publication has 22 references indexed in Scilit:
- Liquid extraction surface analysis mass spectrometry (LESA‐MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine exampleRapid Communications in Mass Spectrometry, 2011
- Open access liquid chromatography/tandem mass spectrometry: implementation of a fully quantitative system in a drug discovery laboratoryInternational Journal of High Throughput Screening, 2010
- Autoradiography, MALDI-MS, and SIMS-MS Imaging in Pharmaceutical Discovery and DevelopmentThe AAPS Journal, 2009
- Exploratory drug safety: A discovery strategy to reduce attrition in developmentJournal of Pharmacological and Toxicological Methods, 2009
- Whatever happened to cassette-dosing pharmacokinetics?Drug Discovery Today, 2004
- Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissuesNature Medicine, 2001
- Cassette dosing: rapid in vivo assessment of pharmacokineticsPharmaceutical Science & Technology Today, 1998
- Rapid Determination of Oral Pharmacokinetics and Plasma Free Fraction Using Cocktail Approaches: Methods and ApplicationPharmaceutical Research, 1998
- Simultaneous Pharmacokinetic Screening of a Mixture of Compounds in the Dog Using API LC/MS/MS Analysis for Increased ThroughputJournal of Medicinal Chemistry, 1997
- The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as anIn Vivo Drug Screening ProcedureRapid Communications in Mass Spectrometry, 1997